Symbols / HIMS $20.33 +6.22% Hims & Hers Health, Inc.
HIMS Chart
About
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 4.63B |
| Enterprise Value | 4.91B | Income | 128.37M | Sales | 2.35B |
| Book/sh | 2.38 | Cash/sh | 2.53 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2442 | IPO | — |
| P/E | 39.86 | Forward P/E | 12.30 | PEG | — |
| P/S | 1.97 | P/B | 8.54 | P/C | — |
| EV/EBITDA | 27.93 | EV/Sales | 2.09 | Quick Ratio | 1.51 |
| Current Ratio | 1.90 | Debt/Eq | 207.16 | LT Debt/Eq | — |
| EPS (ttm) | 0.51 | EPS next Y | 1.65 | EPS Growth | -17.40% |
| Revenue Growth | 28.40% | Earnings | 2026-05-04 | ROA | 5.29% |
| ROE | 25.23% | ROIC | — | Gross Margin | 73.83% |
| Oper. Margin | 2.72% | Profit Margin | 5.47% | Shs Outstand | 219.56M |
| Shs Float | 207.36M | Short Float | 45.18% | Short Ratio | 2.17 |
| Short Interest | — | 52W High | 70.43 | 52W Low | 13.74 |
| Beta | 2.31 | Avg Volume | 34.93M | Volume | 19.39M |
| Target Price | $24.15 | Recom | Hold | Prev Close | $19.14 |
| Price | $20.33 | Change | 6.22% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-27 | main | TD Cowen | Hold → Hold | $23 |
| 2026-03-16 | main | Leerink Partners | Market Perform → Market Perform | $25 |
| 2026-03-11 | main | Barclays | Overweight → Overweight | $29 |
| 2026-03-10 | up | Citigroup | Sell → Neutral | $24 |
| 2026-03-10 | main | Deutsche Bank | Hold → Hold | $28 |
| 2026-03-10 | up | B of A Securities | Underperform → Neutral | $23 |
| 2026-03-09 | up | Needham | Hold → Buy | $30 |
| 2026-02-25 | main | Barclays | Overweight → Overweight | $25 |
| 2026-02-25 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $21 |
| 2026-02-24 | main | Leerink Partners | Market Perform → Market Perform | $18 |
| 2026-02-24 | down | BTIG | Buy → Neutral | — |
| 2026-02-24 | main | Citigroup | Sell → Sell | $13 |
| 2026-02-24 | main | TD Cowen | Hold → Hold | $17 |
| 2026-02-24 | reit | Truist Securities | Hold → Hold | $18 |
| 2026-02-24 | main | Evercore ISI Group | In-Line → In-Line | $24 |
| 2026-02-09 | main | TD Cowen | Hold → Hold | $20 |
| 2026-02-09 | main | Citigroup | Sell → Sell | $17 |
| 2026-02-09 | main | B of A Securities | Underperform → Underperform | $21 |
| 2026-02-02 | main | BTIG | Buy → Buy | $60 |
| 2026-01-12 | init | Evercore ISI Group | — → In-Line | $33 |
- Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN Fri, 03 Apr 2026 20
- Hims & Hers shares rise as investors refocus on growth outlook despite recent data-breach disclosure - Quiver Quantitative Mon, 06 Apr 2026 17
- Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Yahoo Finance Sun, 15 Mar 2026 07
- Hims & Hers Health (NYSE:HIMS) Shares Gap Up - Here's Why - MarketBeat Mon, 06 Apr 2026 16
- Should You Buy Hims Stock Today? - The Motley Fool Fri, 03 Apr 2026 01
- Hims & Hers Stock Fell 11.5% After Novo Deal Bounce. Here’s What the Market Is Pricing In - TIKR.com Mon, 23 Mar 2026 07
- Why Hims & Hers Health Stock Is Surging Now - TipRanks Mon, 06 Apr 2026 16
- Hims & Hers Advances a Consumer-Centric Digital Health Platform - TradingView Mon, 06 Apr 2026 16
- Hims & Hers Health stock climbs as price remains inside $18.90–$20.90 range - Traders Union Mon, 06 Apr 2026 15
- Hims & Hers Announces Strategic Shift for US Weight Loss Business - HIMS Investor Relations Mon, 09 Mar 2026 07
- HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits ue, 31 Mar 2026 13
- Should You Buy Hims Stock Today? - The Globe and Mail Fri, 03 Apr 2026 02
- $HIMS stock fell 12% this week. Here's what we see in our data. - Quiver Quantitative Sat, 28 Mar 2026 07
- Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com Wed, 01 Apr 2026 13
- Hims & Hers (HIMS) Tumbles 8.86% on Market Bloodbath, Profit-Taking - Yahoo Finance Sat, 21 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2,347.64
+59.00%
|
1,476.51
+69.33%
|
872.00
+65.49%
|
526.92
|
| Operating Revenue |
|
2,347.64
+59.00%
|
1,476.51
+69.33%
|
872.00
+65.49%
|
526.92
|
| Cost Of Revenue |
|
614.26
+102.47%
|
303.38
+93.17%
|
157.05
+32.88%
|
118.19
|
| Reconciled Cost Of Revenue |
|
614.26
+102.47%
|
303.38
+93.17%
|
157.05
+32.88%
|
118.19
|
| Gross Profit |
|
1,733.38
+47.76%
|
1,173.13
+64.09%
|
714.95
+74.92%
|
408.72
|
| Operating Expense |
|
1,627.77
+46.48%
|
1,111.23
+49.28%
|
744.40
+55.92%
|
477.42
|
| Research And Development |
|
149.30
+89.42%
|
78.82
+63.43%
|
48.23
+64.95%
|
29.24
|
| Selling General And Administration |
|
1,192.02
+40.80%
|
846.61
+46.90%
|
576.32
+55.43%
|
370.78
|
| Selling And Marketing Expense |
|
919.30
+35.42%
|
678.84
+52.06%
|
446.44
+63.78%
|
272.59
|
| General And Administrative Expense |
|
272.72
+62.56%
|
167.77
+29.17%
|
129.88
+32.27%
|
98.19
|
| Other Gand A |
|
272.72
+62.56%
|
167.77
+29.17%
|
129.88
+32.27%
|
98.19
|
| Other Operating Expenses |
|
286.44
+54.17%
|
185.80
+55.02%
|
119.86
+54.85%
|
77.40
|
| Total Expenses |
|
2,242.02
+58.49%
|
1,414.61
+56.93%
|
901.45
+51.35%
|
595.61
|
| Operating Income |
|
105.61
+70.61%
|
61.90
+310.18%
|
-29.45
+57.13%
|
-68.70
|
| Total Operating Income As Reported |
|
105.61
+70.61%
|
61.90
+310.18%
|
-29.45
+57.13%
|
-68.70
|
| EBITDA |
|
160.12
+102.70%
|
78.99
+496.18%
|
-19.94
+67.43%
|
-61.22
|
| Normalized EBITDA |
|
155.68
+97.08%
|
78.99
+496.18%
|
-19.94
+67.43%
|
-61.22
|
| Reconciled Depreciation |
|
54.50
+218.95%
|
17.09
+79.59%
|
9.52
+27.31%
|
7.47
|
| EBIT |
|
105.61
+70.61%
|
61.90
+310.18%
|
-29.45
+57.13%
|
-68.70
|
| Total Unusual Items |
|
4.44
|
—
|
—
|
0.07
|
| Total Unusual Items Excluding Goodwill |
|
4.44
|
—
|
—
|
0.07
|
| Net Income |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Pretax Income |
|
123.92
+72.81%
|
71.71
+432.44%
|
-21.57
+67.17%
|
-65.71
|
| Net Non Operating Interest Income Expense |
|
—
|
—
|
—
|
—
|
| Interest Expense Non Operating |
|
—
|
—
|
—
|
—
|
| Net Interest Income |
|
—
|
—
|
—
|
—
|
| Interest Expense |
|
—
|
—
|
—
|
—
|
| Other Income Expense |
|
18.31
+86.69%
|
9.81
+24.44%
|
7.88
+163.79%
|
2.99
|
| Other Non Operating Income Expenses |
|
13.87
+41.46%
|
9.81
+24.44%
|
7.88
+163.79%
|
2.99
|
| Gain On Sale Of Security |
|
4.44
|
—
|
—
|
0.07
|
| Tax Provision |
|
-4.44
+91.83%
|
-54.33
-2850.73%
|
1.98
+6470.97%
|
-0.03
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+44391.53%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.93
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Net Income From Continuing Operation Net Minority Interest |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Net Income From Continuing And Discontinued Operation |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Net Income Continuous Operations |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Normalized Income |
|
124.86
-0.93%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Net Income Common Stockholders |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Diluted EPS |
|
0.51
-3.77%
|
0.53
+581.82%
|
-0.11
+65.63%
|
-0.32
|
| Basic EPS |
|
0.57
-1.72%
|
0.58
+627.27%
|
-0.11
+65.63%
|
-0.32
|
| Basic Average Shares |
|
224.96
+4.18%
|
215.94
+3.15%
|
209.34
+2.36%
|
204.52
|
| Diluted Average Shares |
|
258.23
+9.05%
|
236.81
+13.12%
|
209.34
+2.36%
|
204.52
|
| Diluted NI Availto Com Stockholders |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
2,154.70
+204.54%
|
707.54
+60.37%
|
441.19
+20.43%
|
366.34
|
| Current Assets |
|
767.64
+93.93%
|
395.83
+49.34%
|
265.05
+22.37%
|
216.59
|
| Cash Cash Equivalents And Short Term Investments |
|
577.49
+92.34%
|
300.25
+35.87%
|
220.98
+23.02%
|
179.62
|
| Cash And Cash Equivalents |
|
228.62
+3.64%
|
220.58
+128.20%
|
96.66
+106.67%
|
46.77
|
| Other Short Term Investments |
|
348.88
+337.92%
|
79.67
-35.92%
|
124.32
-6.42%
|
132.85
|
| Receivables |
|
32.15
+428.77%
|
6.08
-9.90%
|
6.75
+108.85%
|
3.23
|
| Accounts Receivable |
|
32.15
+428.77%
|
6.08
-9.90%
|
6.75
+108.85%
|
3.23
|
| Inventory |
|
80.13
+24.37%
|
64.43
+186.80%
|
22.46
+4.18%
|
21.56
|
| Raw Materials |
|
53.15
+81.09%
|
29.35
+305.22%
|
7.24
+42.44%
|
5.08
|
| Finished Goods |
|
26.98
-23.09%
|
35.08
+130.45%
|
15.22
-7.62%
|
16.48
|
| Prepaid Assets |
|
73.50
+197.88%
|
24.67
+131.35%
|
10.66
+2.63%
|
10.39
|
| Current Deferred Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
4.37
+993.50%
|
0.40
-90.46%
|
4.20
+135.01%
|
1.78
|
| Total Non Current Assets |
|
1,387.07
+344.99%
|
311.71
+76.97%
|
176.13
+17.62%
|
149.75
|
| Net PPE |
|
448.98
+382.96%
|
92.96
+103.28%
|
45.73
+183.43%
|
16.14
|
| Gross PPE |
|
501.56
+327.00%
|
117.46
+102.61%
|
57.98
+159.09%
|
22.38
|
| Accumulated Depreciation |
|
-52.59
-114.66%
|
-24.50
-100.09%
|
-12.24
-96.19%
|
-6.24
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
134.31
+117.03%
|
61.88
+98.20%
|
31.22
+99.48%
|
15.65
|
| Other Properties |
|
351.33
+686.94%
|
44.65
+82.26%
|
24.50
+272.94%
|
6.57
|
| Leases |
|
15.93
+45.66%
|
10.93
+384.62%
|
2.26
+1355.48%
|
0.15
|
| Goodwill And Other Intangible Assets |
|
474.44
+203.86%
|
156.14
+20.61%
|
129.46
-2.46%
|
132.72
|
| Goodwill |
|
278.32
+146.90%
|
112.73
+1.67%
|
110.88
+0.00%
|
110.88
|
| Other Intangible Assets |
|
196.12
+351.78%
|
43.41
+133.71%
|
18.57
-14.96%
|
21.84
|
| Investments And Advances |
|
351.26
|
0.00
|
—
|
—
|
| Non Current Deferred Assets |
|
82.71
+34.26%
|
61.60
|
0.00
|
—
|
| Non Current Deferred Taxes Assets |
|
82.71
+34.26%
|
61.60
|
0.00
|
—
|
| Other Non Current Assets |
|
29.68
+2859.12%
|
1.00
+5.91%
|
0.95
+6.52%
|
0.89
|
| Total Liabilities Net Minority Interest |
|
1,613.78
+599.14%
|
230.82
+137.58%
|
97.16
+77.94%
|
54.60
|
| Current Liabilities |
|
404.43
+82.70%
|
221.37
+150.22%
|
88.47
+84.54%
|
47.94
|
| Payables And Accrued Expenses |
|
268.78
+86.40%
|
144.19
+81.48%
|
79.45
+77.31%
|
44.81
|
| Payables |
|
199.90
+114.18%
|
93.33
+84.88%
|
50.48
+51.48%
|
33.33
|
| Accounts Payable |
|
143.28
+57.14%
|
91.18
+111.70%
|
43.07
+33.08%
|
32.36
|
| Other Payable |
|
46.99
|
—
|
7.41
|
—
|
| Current Accrued Expenses |
|
68.88
+35.43%
|
50.86
+75.55%
|
28.97
+152.26%
|
11.48
|
| Total Tax Payable |
|
9.64
+347.77%
|
2.15
+7.12%
|
2.01
+108.62%
|
0.96
|
| Current Debt And Capital Lease Obligation |
|
4.84
+156.38%
|
1.89
+47.46%
|
1.28
-22.74%
|
1.66
|
| Current Capital Lease Obligation |
|
4.84
+156.38%
|
1.89
+47.46%
|
1.28
-22.74%
|
1.66
|
| Current Deferred Liabilities |
|
127.16
+68.90%
|
75.28
+873.55%
|
7.73
+425.34%
|
1.47
|
| Current Deferred Revenue |
|
127.16
+68.90%
|
75.28
+873.55%
|
7.73
+425.34%
|
1.47
|
| Other Current Liabilities |
|
3.65
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1,209.35
+12689.19%
|
9.46
+8.83%
|
8.69
+30.49%
|
6.66
|
| Long Term Debt And Capital Lease Obligation |
|
1,115.75
+11699.35%
|
9.46
+9.10%
|
8.67
+137.52%
|
3.65
|
| Long Term Debt |
|
972.58
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
143.17
+1414.03%
|
9.46
+9.10%
|
8.67
+137.52%
|
3.65
|
| Non Current Deferred Liabilities |
|
28.86
|
0.00
|
—
|
—
|
| Non Current Deferred Taxes Liabilities |
|
28.86
|
0.00
|
—
|
—
|
| Other Non Current Liabilities |
|
64.74
|
—
|
0.02
-99.27%
|
3.01
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
540.93
+13.47%
|
476.72
+38.57%
|
344.03
+10.36%
|
311.74
|
| Common Stock Equity |
|
540.93
+13.47%
|
476.72
+38.57%
|
344.03
+10.36%
|
311.74
|
| Capital Stock |
|
0.02
+4.55%
|
0.02
+4.76%
|
0.02
+0.00%
|
0.02
|
| Common Stock |
|
0.02
+4.55%
|
0.02
+4.76%
|
0.02
+0.00%
|
0.02
|
| Share Issued |
|
227.25
+2.90%
|
220.84
+3.45%
|
213.48
+2.42%
|
208.43
|
| Ordinary Shares Number |
|
227.25
+2.90%
|
220.84
+3.45%
|
213.48
+2.42%
|
208.43
|
| Additional Paid In Capital |
|
652.38
-9.28%
|
719.15
+0.96%
|
712.31
+8.48%
|
656.63
|
| Retained Earnings |
|
-113.77
+53.01%
|
-242.14
+34.23%
|
-368.18
-6.83%
|
-344.63
|
| Gains Losses Not Affecting Retained Earnings |
|
2.29
+808.02%
|
-0.32
-161.29%
|
-0.12
+55.23%
|
-0.28
|
| Other Equity Adjustments |
|
2.29
+808.02%
|
-0.32
-161.29%
|
-0.12
+55.23%
|
-0.28
|
| Total Equity Gross Minority Interest |
|
540.93
+13.47%
|
476.72
+38.57%
|
344.03
+10.36%
|
311.74
|
| Total Capitalization |
|
1,513.51
+217.49%
|
476.72
+38.57%
|
344.03
+10.36%
|
311.74
|
| Working Capital |
|
363.21
+108.18%
|
174.46
-1.20%
|
176.59
+4.70%
|
168.65
|
| Invested Capital |
|
1,513.51
+217.49%
|
476.72
+38.57%
|
344.03
+10.36%
|
311.74
|
| Total Debt |
|
1,120.59
+9777.39%
|
11.35
+14.04%
|
9.95
+87.45%
|
5.31
|
| Net Debt |
|
743.96
|
—
|
—
|
—
|
| Capital Lease Obligations |
|
148.01
+1204.63%
|
11.35
+14.04%
|
9.95
+87.45%
|
5.31
|
| Net Tangible Assets |
|
66.49
-79.26%
|
320.58
+49.40%
|
214.57
+19.86%
|
179.02
|
| Tangible Book Value |
|
66.49
-79.26%
|
320.58
+49.40%
|
214.57
+19.86%
|
179.02
|
| Available For Sale Securities |
|
351.26
|
—
|
—
|
—
|
| Investmentin Financial Assets |
|
351.26
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
300.01
+19.48%
|
251.08
+241.69%
|
73.48
+376.97%
|
-26.53
|
| Cash Flow From Continuing Operating Activities |
|
300.01
+19.48%
|
251.08
+241.69%
|
73.48
+376.97%
|
-26.53
|
| Net Income From Continuing Operations |
|
128.37
+1.85%
|
126.04
+635.28%
|
-23.55
+64.15%
|
-65.68
|
| Depreciation Amortization Depletion |
|
54.50
+218.95%
|
17.09
+79.59%
|
9.52
+27.31%
|
7.47
|
| Depreciation And Amortization |
|
54.50
+218.95%
|
17.09
+79.59%
|
9.52
+27.31%
|
7.47
|
| Other Non Cash Items |
|
29.95
+931.86%
|
2.90
-50.65%
|
5.88
+148.02%
|
2.37
|
| Stock Based Compensation |
|
135.24
+46.49%
|
92.32
+39.71%
|
66.08
+54.33%
|
42.82
|
| Asset Impairment Charge |
|
0.53
+365.79%
|
0.11
-73.43%
|
0.43
-61.93%
|
1.13
|
| Deferred Tax |
|
-12.96
+78.98%
|
-61.65
-474123.08%
|
-0.01
+97.81%
|
-0.59
|
| Deferred Income Tax |
|
-12.96
+78.98%
|
-61.65
-474123.08%
|
-0.01
+97.81%
|
-0.59
|
| Operating Gains Losses |
|
—
|
—
|
—
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
-4.44
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-29.16
-137.09%
|
78.62
+277.61%
|
20.82
+246.68%
|
-14.20
|
| Change In Inventory |
|
-13.72
+67.02%
|
-41.61
-4513.30%
|
-0.90
+88.73%
|
-8.00
|
| Change In Prepaid Assets |
|
-51.86
-446.20%
|
-9.49
-48.46%
|
-6.39
-0.95%
|
-6.33
|
| Change In Payables And Accrued Expense |
|
-12.76
-119.72%
|
64.68
+171.20%
|
23.85
+591.65%
|
3.45
|
| Change In Accrued Expense |
|
-43.05
-280.96%
|
23.79
+43.98%
|
16.52
+1717.82%
|
0.91
|
| Change In Payable |
|
30.30
-25.90%
|
40.88
+458.23%
|
7.32
+188.46%
|
2.54
|
| Change In Account Payable |
|
30.30
-30.69%
|
43.71
+496.81%
|
7.32
-42.43%
|
12.72
|
| Change In Other Working Capital |
|
51.60
-23.61%
|
67.55
+978.93%
|
6.26
+464.86%
|
-1.72
|
| Change In Other Current Assets |
|
-0.52
-825.00%
|
-0.06
+3.45%
|
-0.06
-441.18%
|
0.02
|
| Change In Other Current Liabilities |
|
-1.91
+21.69%
|
-2.44
-26.38%
|
-1.93
-20.44%
|
-1.60
|
| Investing Cash Flow |
|
-1,024.96
-5280.92%
|
-19.05
-57.34%
|
-12.11
-134.89%
|
34.70
|
| Cash Flow From Continuing Investing Activities |
|
-1,024.96
-5280.92%
|
-19.05
-57.34%
|
-12.11
-134.89%
|
34.70
|
| Net PPE Purchase And Sale |
|
-226.04
-442.66%
|
-41.66
-141.90%
|
-17.22
-534.49%
|
-2.71
|
| Purchase Of PPE |
|
-226.04
-442.66%
|
-41.66
-141.90%
|
-17.22
-534.49%
|
-2.71
|
| Capital Expenditure |
|
-242.59
-359.89%
|
-52.75
-99.12%
|
-26.49
-265.56%
|
-7.25
|
| Net Investment Purchase And Sale |
|
-637.14
-1397.61%
|
49.10
+241.31%
|
14.39
-66.07%
|
42.41
|
| Purchase Of Investment |
|
-745.84
-364.51%
|
-160.56
-2.11%
|
-157.24
+16.23%
|
-187.70
|
| Sale Of Investment |
|
108.70
-48.16%
|
209.66
+22.16%
|
171.62
-25.41%
|
230.10
|
| Net Business Purchase And Sale |
|
-145.23
-843.09%
|
-15.40
|
0.00
+100.00%
|
-0.46
|
| Purchase Of Business |
|
-145.23
-843.09%
|
-15.40
|
0.00
+100.00%
|
-0.46
|
| Net Intangibles Purchase And Sale |
|
-16.55
-49.13%
|
-11.10
-19.66%
|
-9.27
-104.54%
|
-4.53
|
| Purchase Of Intangibles |
|
-16.55
-49.13%
|
-11.10
-19.66%
|
-9.27
-104.54%
|
-4.53
|
| Financing Cash Flow |
|
729.62
+776.55%
|
-107.84
-839.83%
|
-11.47
+65.36%
|
-33.13
|
| Cash Flow From Continuing Financing Activities |
|
729.62
+776.55%
|
-107.84
-839.83%
|
-11.47
+65.36%
|
-33.13
|
| Net Issuance Payments Of Debt |
|
970.00
|
0.00
|
0.00
|
0.00
|
| Issuance Of Debt |
|
970.00
|
0.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
970.00
|
0.00
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
970.00
|
0.00
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
-89.96
-8.33%
|
-83.04
-4054.03%
|
-2.00
|
0.00
|
| Common Stock Payments |
|
-89.96
-8.33%
|
-83.04
-4054.03%
|
-2.00
|
0.00
|
| Repurchase Of Capital Stock |
|
-89.96
-8.33%
|
-83.04
-4054.03%
|
-2.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
17.47
-43.43%
|
30.89
+568.51%
|
4.62
+34.93%
|
3.42
|
| Net Other Financing Charges |
|
-167.89
-201.47%
|
-55.69
-295.08%
|
-14.10
+61.43%
|
-36.55
|
| Changes In Cash |
|
4.67
-96.24%
|
124.19
+148.87%
|
49.90
+299.94%
|
-24.96
|
| Effect Of Exchange Rate Changes |
|
2.51
+1028.89%
|
-0.27
-2354.55%
|
-0.01
+79.25%
|
-0.05
|
| Beginning Cash Position |
|
221.44
+127.07%
|
97.52
+104.75%
|
47.63
-34.43%
|
72.64
|
| End Cash Position |
|
228.62
+3.24%
|
221.44
+127.07%
|
97.52
+104.75%
|
47.63
|
| Free Cash Flow |
|
57.41
-71.05%
|
198.33
+322.07%
|
46.99
+239.12%
|
-33.78
|
| Interest Paid Supplemental Data |
|
—
|
—
|
—
|
0.00
|
| Income Tax Paid Supplemental Data |
|
23.16
+192.60%
|
7.92
+613.80%
|
1.11
+74.37%
|
0.64
|
| Amortization Of Securities |
|
-2.03
+53.34%
|
-4.36
+23.41%
|
-5.69
-3994.52%
|
0.15
|
| Common Stock Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
0.00
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-24 View
- 42026-03-18 View
- 42026-03-18 View
- 42026-03-18 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
- 42026-03-13 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|